Back to search

Article

Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.

2024-01-03

Abstract excerpt

<title>Abstract</title> <p>Background Convalescent Plasma (CP) reduced the mortality in COVID-19 induced ARDS (C-ARDS) patients treated in the CONFIDENT trial. As patients are immunologically heterogeneous, we hypothesized that clusters may differ in their treatment responses to CP. Methods We measured 20 cytokines, chemokines and cell adhesion markers using a multiplex technique at the time of inclusion in the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5011feea-3b4a-51be-8437-c8f9690620dd
DOI
10.21203/rs.3.rs-3793271/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.DOI 10.21203/rs.3.rs-3793271/v1
Select a neighboring publication to make it the new centre.